As part of the ongoing World Psychiatric Association (WPA) Webinar Series, the 'Recent Advances in the treatment of Depression' webinar took place on Wednesday 1st June 2022 at 6pm GMT.
The event was moderated by Prof Konstantinos Fountoulakis MD PhD and included presentations from Professor Siegfried Kasper (Austria) on ‘Treatment Resistant Depression: From Research to Practice’ and Professor Michael Thase (USA) on ‘Pharmacotherapy of Depression: Guideline Based Strategies for Initial and Long-Term Benefits’ followed by Q&A.
The WPA webinar on Depression Clinical Management aims to address clinical doctors, who would like to enrich their practical experience in the treatment of depressions to bring patients back to their families and even to their job.
Depressive disorders are a mental disorder characterised by relapsing episodes which often develop eventually into chronic depression associated with high rates of disability and death by suicide. Because of its high prevalence, depression is the number one cause of disability because of mental illness.
A significant proportion of patients will never recover completely and repeated hospitalisations or life-long protective living might be necessary for some. The majority of patients will live a relatively functional life; however, often with significant difficulty, distress and misery. Social problems, such as long-term unemployment, poverty, homelessness, exploitation and victimisation as well as problems with the law are commonly correlated with depression. The treatment includes medication, along with psychotherapy, counselling and social rehabilitation.
A recording of the webinar is now available for viewing on WPA’s Education Portal here.
For any queries relating to this education module or the WPA Education Portal in general, please contact email@example.com.
Author: WPA Education Coordinator